Regulation of Normal Differentiation in Mouse and Human Myeloid Leukemic Cells by Phorbol Esters and the Mechanism of Tumor Promotion

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1979 Oct 1

PMID 291929

Citations 61

Authors

J Lotem

L Sachs

Affiliations

Soon will be listed here.

Abstract

The control of cell multiplication and differentiation by tumor-promoting phorbol esters including 12-O-tetradecanoylphorbol-13-acetate (TPA) has been studied with different clones of mouse myeloid leukemic cells, a line of human myeloid leukemic cells, and normal mouse bone marrow myeloblasts. TPA induced normal cell differentiation in one of the mouse leukemic clones and this was mediated by induction of the protein inducer of differentiation to macrophages or granulocytes (MGI) in the cells that then differentiated. Other mouse clones were not induced to differentiate by TPA. In one of these clones, TPA induced cell susceptibility to externally added MGI. This effect was not due to a general induction of susceptibility to all compounds because TPA did not induce susceptibility to lypopolysaccharide or dexamethasone in this clone. In the human leukemic cell line, TPA also induced differentiation with the induction of MGI activity and enhanced susceptibility to added MGI. It is suggested that the clonal differences in induction of MGI activity and increased susceptibility to MGI may be associated with differences in receptors for TPA and the ability of TPA to modify receptors for MGI. Studies with normal bone marrow cells have indicated that TPA stimulated MGI activity and also increased susceptibility of normal myeloblasts to induction of multiplication by MGI. The ability of different phorbol esters to produce these effects on normal myeloblasts and myeloid leukemic cells paralleled their ability to act as tumor promoters. The results indicate that a tumor promoter such as TPA can induce the production of and increase cell susceptibility to a normal regulator of cell multiplication and differentiation. TPA has pleiotropic effects. It is suggested that, by these mechanisms, TPA may thus act as a tumor promoter by increasing cell multiplication in initiated cells, induce differentiation in some cells, or inhibit differentiation in other cells, depending on which molecules are being regulated in the TPA-treated cells.

Citing Articles

seed oil for possible human consumption: A toxicological assessment of its phorbol esters.

Cao X, Wei X, Shao Y, Li D, Zhu J Toxicol Rep. 2025; 14():101870.

PMID: 39802603 PMC: 11721233. DOI: 10.1016/j.toxrep.2024.101870.

Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations.

Vikram E, Ilavarasan R, Kamaraj R J Ayurveda Integr Med. 2022; 13(2):100545.

PMID: 35661925 PMC: 9163510. DOI: 10.1016/j.jaim.2022.100545.

Involvement of CD11b integrin in the alteration of metabolic factors after phorbol ester stimulation of human myeloid leukemia cells.

Mandel K, Otte A, Hass R Cell Commun Signal. 2012; 10(1):13.

PMID: 22607136 PMC: 3394204. DOI: 10.1186/1478-811X-10-13.

Abolished adherence alters signaling pathways in phorbol ester-induced human U937 cells.

Otte A, Mandel K, Reinstrom G, Hass R Cell Commun Signal. 2011; 9:20.

PMID: 21939515 PMC: 3191470. DOI: 10.1186/1478-811X-9-20.

M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification.

Jack G, Zhang L, Friedman A Blood. 2009; 114(10):2172-80.

PMID: 19587381 PMC: 2744575. DOI: 10.1182/blood-2008-11-191536.

References

Rovera G, OBrien T, Diamond L . Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture. Proc Natl Acad Sci U S A. 1977; 74(7):2894-8. PMC: 431336. DOI: 10.1073/pnas.74.7.2894. View

Yamasaki H, Fibach E, Nudel U, Weinstein I, Rifkind R, Marks P . Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture. Proc Natl Acad Sci U S A. 1977; 74(8):3451-5. PMC: 431603. DOI: 10.1073/pnas.74.8.3451. View

Lee L, Weinstein I . Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors. Science. 1978; 202(4365):313-5. DOI: 10.1126/science.308698. View

Liebermann D, Sachs L . Increase of normal myeloblast viability and multiplication without blocking differentiation by type C RNA virus from myeloid leukemic cells. Proc Natl Acad Sci U S A. 1979; 76(7):3353-7. PMC: 383823. DOI: 10.1073/pnas.76.7.3353. View

zur Hausen H, Bornkamm G, Schmidt R, Hecker E . Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci U S A. 1979; 76(2):782-5. PMC: 383050. DOI: 10.1073/pnas.76.2.782. View

Wiener F, Spira J, Ohno S, Haran-Ghera N, Klein G . Chromosome changes (trisomy 15) in murine T-cell leukemia induced by 1,12-dimethylbenz(a)anthracene (DMBA). Int J Cancer. 1978; 22(4):447-53. DOI: 10.1002/ijc.2910220413. View

Miller E . Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. Cancer Res. 1978; 38(6):1479-96. View

Gerassi E, Sachs L . Regulation of human T cell colonies by an inducing activity (TCI) produced by normal human and malignant mouse cells. J Immunol. 1978; 121(6):2547-53. View

Lotem J, Sachs L . In vivo induction of normal differentiation in myeloid leukemia cells. Proc Natl Acad Sci U S A. 1978; 75(8):3781-5. PMC: 392870. DOI: 10.1073/pnas.75.8.3781. View

10.

Sachs L . Regulation of actin and other proteins in the differentiation of myeloid leukemic cells. Cell. 1978; 14(4):825-34. DOI: 10.1016/0092-8674(78)90338-0. View

11.

Sachs L . Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature. 1978; 274(5671):535-9. DOI: 10.1038/274535a0. View

12.

Kinsella A, Radman M . Tumor promoter induces sister chromatid exchanges: relevance to mechanisms of carcinogenesis. Proc Natl Acad Sci U S A. 1978; 75(12):6149-53. PMC: 393136. DOI: 10.1073/pnas.75.12.6149. View

13.

Barrett J, Tso P . Evidence for the progressive nature of neoplastic transformation in vitro. Proc Natl Acad Sci U S A. 1978; 75(8):3761-5. PMC: 392866. DOI: 10.1073/pnas.75.8.3761. View

14.

Fibach E, Yamasaki H, Weinstein I, Marks P, Rifkind R . Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation. Cancer Res. 1978; 38(11 Pt 1):3685-8. View

15.

Collins S, Ruscetti F, Gallagher R, Gallo R . Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A. 1978; 75(5):2458-62. PMC: 392573. DOI: 10.1073/pnas.75.5.2458. View

16.

Weiss B, Sachs L . Indirect induction of differentiation in myeloid leukemic cells by lipid A. Proc Natl Acad Sci U S A. 1978; 75(3):1374-8. PMC: 411474. DOI: 10.1073/pnas.75.3.1374. View

17.

Rowley J . Mapping of human chromosomal regions related to neoplasia: evidence from chromosomes 1 and 17. Proc Natl Acad Sci U S A. 1977; 74(12):5729-33. PMC: 431867. DOI: 10.1073/pnas.74.12.5729. View

18.

Lotem J, Sachs L . Genetic dissection of the control of normal differentiation in myeloid leukemic cells. Proc Natl Acad Sci U S A. 1977; 74(12):5554-8. PMC: 431806. DOI: 10.1073/pnas.74.12.5554. View

19.

Collins S, Gallo R, Gallagher R . Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 1977; 270(5635):347-9. DOI: 10.1038/270347a0. View

20.

Azumi J, Sachs L . Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells. Proc Natl Acad Sci U S A. 1977; 74(1):253-7. PMC: 393237. DOI: 10.1073/pnas.74.1.253. View